Gilead Sciences Inc. Earnings

Gilead Sciences Inc.’s revenue jumped 1.84% since last year same period to $7081Mn in the Q2 2025. On a quarterly growth basis, Gilead Sciences Inc. has generated 6.21% jump in its revenue since last 3-months.

Gilead Sciences Inc.’s net profit jumped 21.44% since last year same period to $1960Mn in the Q2 2025. On a quarterly growth basis, Gilead Sciences Inc. has generated 49.05% jump in its net profits since last 3-months.

Gilead Sciences Inc.’s net profit margin jumped 19.24% since last year same period to 27.68% in the Q2 2025. On a quarterly growth basis, Gilead Sciences Inc. has generated 40.34% jump in its net profit margins since last 3-months.

Gilead Sciences Inc.’s price-to-earnings ratio after this Q2 2025 earnings stands at 23.41.

Gilead Sciences Inc.’s earning per share (EPS) estimates for the current quarter stand at 2.16 - a 10.2% jump from last quarter’s estimates.

Gilead Sciences Inc.’s earning per share (EPS) estimates for the current year stand at 2.16.

Gilead Sciences Inc.’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Gilead Sciences Inc. has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Gilead Sciences Inc. declared 0.79 dividend per share during the earnings announcement for Q3 2025.